A growing body of literature has documented emotional disorders in patients with dementia with Lewy bodies (DLB). While emotional symptoms have been well studied in Alzheimer's disease (AD) and Parkinson's disease (PD), no study to date has provided a comprehensive overview of emotional disturbances specifically associated with DLB.
Objective
This study aimed to investigate the emotional profile of patients with prodromal or mild DLB compared to healthy controls.
Methods
Behavioral data were collected from 24 prodromal or mild DLB patients, and 24 healthy participants, matched for age, gender and educational level. Statistics, including group comparisons and correlation analyses, were conducted using the following measures: the Florida Affect Battery (FAB), the 20-item Toronto Alexithymia Scale (TAS-20), the Echelle d’Humeur Depressive (EHD), and the Generalized Anxiety Disorder 7-item (GAD-7) scale.
Results
Patients with DLB demonstrated significantly impaired performance on the FAB alongside elevated scores on the TAS-20, the EHD, and the GAD-7 compared to controls.
Conclusions
These findings highlight profound disruptions in internal emotional experience among patients with prodromal or mild DLB, notably marked by elevated alexithymic traits, altered emotional expression, emotional dyscontrol, anxiety, and impairments in automatic and implicit recognition of facial emotions. Our study supports the critical need for early detection, systematic evaluation, and personalized management of emotional symptoms through targeted interventions.
McKeithIGBoeveBFDicksonDW, et al.Diagnosis and management of dementia with Lewy bodies. Neurology2017; 89: 88–100.
2.
McKeithIGFermanTJThomasAJ, et al.Research criteria for the diagnosis of prodromal dementia with Lewy bodies. Neurology2020; 94: 743–755.
3.
JurekLHerrmannMBonzeM, et al.Behavioral and psychological symptoms in Lewy body disease: a review. Geriatr Psychol Neuropsychiatr Vieil2018; 16: 87–95.
4.
DonaghyPCCiafoneJDurcanR, et al.Mild cognitive impairment with Lewy bodies: neuropsychiatric supportive symptoms and cognitive profile. Psychol Med2022; 52: 1147–1155.
5.
LiuCLiuSWangX, et al.Neuropsychiatric profiles in mild cognitive impairment with Lewy bodies. Aging Ment Health2021; 25: 2011–2017.
6.
GibsonLLSkogsethREHortobagyiT, et al.Clinical evolution of neuropsychiatric symptoms in Alzheimer’s disease and dementia with Lewy bodies in a post-mortem cohort. Int J Geriatr Psychiatry2025; 40: e70084.
7.
GanJChenZLiuS, et al.The presence and co-incidence of geriatric syndromes in older patients with mild-moderate Lewy body dementia. BMC Neurol2022; 22: 355.
8.
BlancFBouteloupVPaquetC, et al.Prodromal characteristics of dementia with Lewy bodies: baseline results of the MEMENTO memory clinics nationwide cohort. Alzheimers Res Ther2022; 14: 96.
9.
HeitzCNobletVPhillippsC, et al.Cognitive and affective theory of mind in dementia with Lewy bodies and Alzheimer’s disease. Alzheimers Res Ther2016; 8: 10.
10.
MsikaE-FVernyMDieudonnéB, et al.Multidimensional assessment of social cognition using non-immersive virtual reality in dementia with Lewy bodies and Alzheimer’s disease: an exploratory study. J Clin Exp Neuropsychol2024; 46: 488–503.
11.
van den BergNSReesinkFEde HaanEHF, et al.Emotion recognition and traffic-related risk-taking behavior in patients with neurodegenerative diseases. J Int Neuropsychol Soc2021; 27: 136–145.
12.
GalvinJEMalcomHJohnsonD, et al.Personality traits distinguishing dementia with Lewy bodies from Alzheimer disease. Neurology2007; 68: 1895–1901.
13.
KaniniaSMcCarthyRASaadZ, et al.Young-onset dementia with Lewy bodies presenting with apathy and alexithymia. Neurocase2023; 29: 191–194.
14.
AibaYSakakibaraROgataT, et al.Young-onset dementia with Lewy bodies. Case Rep Neurol2018; 10: 363–368.
15.
CárdenasJBlancaMJCarvajalF, et al.Emotional processing in healthy ageing, mild cognitive impairment, and Alzheimer’s disease. Int J Environ Res Public Health2021; 18: 2770.
16.
BecharaADamasioHDamasioAR. Emotion, decision making and the orbitofrontal cortex. Cereb Cortex2000; 10: 295–307.
17.
SotgiuIRusconiML. Investigating emotions in Parkinson’s disease: what we know and what we still don’t know. Front Psychol2013; 4: 336.
18.
JinYMaoZLingZ, et al.Altered emotional recognition and expression in patients with Parkinson’s disease. Neuropsychiatr Dis Treat2017; 13: 2891–2902.
19.
SaenzADoé de MaindrevilleAHenryA, et al.Recognition of facial and musical emotions in Parkinson’s disease. Eur J Neurol2013; 20: 571–577.
20.
WenM-CChanLLTanLCS, et al.Depression, anxiety, and apathy in Parkinson’s disease: insights from neuroimaging studies. Eur J Neurol2016; 23: 1001–1019.
21.
Alvarado-BolañosACervantes-ArriagaAZuazua-VidalL, et al.Determinants and impact of alexithymia on quality of life in Parkinson’s disease. Neurologia (Engl Ed)2023; 38: 334–341.
22.
CulicettoLFormicaCLo BuonoV, et al.Possible implications of managing alexithymia on quality of life in Parkinson’s disease: a systematic review. Parkinsons Dis2024; 2024: 5551796.
23.
da SilvaRCRde CarvalhoRLSDouradoMCN. Deficits in emotion processing in Alzheimer’s disease: a systematic review. Dement Neuropsychol2021; 15: 314–330.
24.
SegersKBenoitFMeytsJ-M, et al.Anxiety symptoms are quantitatively and qualitatively different in dementia with Lewy bodies than in Alzheimer’s disease in the years preceding clinical diagnosis. Psychogeriatrics2020; 20: 242–246.
25.
BarkerMSCosentinoSAFremontR, et al.Towards defining the neuroanatomical basis of late-onset psychiatric symptoms. J Geriatr Psychiatry Neurol2022; 35: 751–762.
26.
FermanTJSmithGEBoeveBF, et al.DLB Fluctuations: specific features that reliably differentiate DLB from AD and normal aging. Neurology2004; 62: 181–187.
27.
FénelonGSoulasTZenasniF, et al.The changing face of Parkinson’s disease-associated psychosis: a cross-sectional study based on the new NINDS-NIMH criteria. Mov Disord2010; 25: 763–766.
28.
Movement Disorder Society Task Force on Rating Scales for Parkinson’s Disease. The unified Parkinson’s disease rating scale (UPDRS): status and recommendations. Mov Disord2003; 18: 738–750.
29.
GjerstadMDBoeveBWentzel-LarsenT, et al.Occurrence and clinical correlates of REM sleep behaviour disorder in patients with Parkinson’s disease over time. J Neurol Neurosurg Psychiatry2008; 79: 387–391.
30.
SheehanDVLecrubierYSheehanKH, et al.The Mini-international neuropsychiatric interview (M.I.N.I.): the development and validation of a structured diagnostic psychiatric interview for DSM-IV and ICD-10. J Clin Psychiatry1998; 59: 22–33;quiz 34-57.
31.
FolsteinMFFolsteinSEMcHughPR. Mini-mental state’. A practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res1975; 12: 189–198.
ShahouzaeiNGhayoumi-AnarakiZMaleki ShahmahmoodT, et al.Changes in speech prosody perception during Parkinson’s disease: a comprehensive analysis. J Commun Disord2024; 110: 106430.
34.
ShimY. Facial emotion recognition in older adults with cognitive complaints. Dement Neurocogn Disord2023; 22: 158–168.
35.
LoasGParkerJDOtmaniO, et al.Confirmatory factor analysis of the French translation of the 20-item Toronto alexithymia scale. Percept Mot Skills1997; 85: 1018.
36.
RadatFLafittauMOualletJC, et al.Validation of EHD self questionnaire in multiple sclerosis. Encephale2007; 33: 49–57.
37.
MontelSBonnetA-MBungenerC. Quality of life in relation to mood, coping strategies, and dyskinesia in Parkinson’s disease. J Geriatr Psychiatry Neurol2009; 22: 95–102.
38.
SpitzerRLKroenkeKWilliamsJBW, et al.A brief measure for assessing generalized anxiety disorder: the GAD-7. Arch Intern Med2006; 166: 1092–1097.
39.
AktürkZHapfelmeierAFomenkoA, et al.Generalized anxiety disorder 7-item (GAD-7) and 2-item (GAD-2) scales for detecting anxiety disorders in adults. Cochrane Database Syst Rev2025; 3: CD015455.
40.
WildBEcklAHerzogW, et al.Assessing generalized anxiety disorder in elderly people using the GAD-7 and GAD-2 scales: results of a validation study. Am J Geriatr Psychiatry2014; 22: 1029–1038.
41.
AlisCDemirelliDSAyE, et al.Depression and anxiety in Parkinson’s disease: prevalence and associated risk factors. Sisli Etfal Hastan Tip Bul2025; 59: 200–205.
42.
RömerBDalenIBallardC, et al.The course of depressive symptoms in Lewy body dementia and Alzheimer’s disease. J Affect Disord2023; 333: 459–467.
43.
ChiuP-YWangC-WTsaiC-T, et al.Depression in dementia with Lewy bodies: a comparison with Alzheimer’s disease. PLoS One2017; 12: e0179399.
44.
GliaudelytėLRushtonSPBerlinguer-PalminiR, et al.Dopaminergic changes in the subgenual cingulate cortex in dementia with Lewy bodies associates with presence of depression. Transl Psychiatry2025; 15: 89.
45.
PattersonLRushtonSPAttemsJ, et al.Degeneration of dopaminergic circuitry influences depressive symptoms in Lewy body disorders. Brain Pathol2019; 29: 544–557.
46.
ChakrabortyADiwanA. Depression and Parkinson’s disease: a chicken-egg story. AIMS Neurosci2022; 9: 479–490.
47.
Del-MonteJBayardSGrazianiP, et al.Cognitive, emotional, and auto-activation dimensions of apathy in Parkinson’s disease. Front Behav Neurosci2017; 11: 230.
48.
JellingerKA. Behavioral disorders in dementia with Lewy bodies: old and new knowledge. J Neural Transm (Vienna)2025; 132: 203–216.
49.
SchwertnerEPereiraJBXuH, et al.Behavioral and psychological symptoms of dementia in different dementia disorders: a large-scale study of 10,000 individuals. J Alzheimers Dis2022; 87: 1307–1318.
50.
ToyaSHashimotoMManabeY, et al.Factors associated with increased burden of caregivers of people with dementia with Lewy bodies. Geriatrics2024; 9: 115.
ContiDBechi GabrielliGPaniguttiM, et al.Neuroanatomical and clinical correlates of prodromal dementia with Lewy bodies: a systematic literature review of neuroimaging findings. J Neurol2024; 272: 38.
53.
PattersonLFirbankMJCollobySJ, et al.Neuropathological changes in dementia with Lewy bodies and the cingulate island sign. J Neuropathol Exp Neurol2019; 78: 717–724.
54.
Mendoza-VelásquezJJFlores-VázquezJFBarrón-VelázquezE, et al.Autonomic dysfunction in α-synucleinopathies. Front Neurol2019; 10: 363.
GilR. 18 - Neuropsychologie des instincts et des émotions. In: GilR (ed.) Neuropsychologie (Huitième Édition). Paris: Elsevier Masson, 2024, pp.366–422.
57.
AssognaFPalmerKPontieriFE, et al.Alexithymia is a non-motor symptom of Parkinson disease. Am J Geriatr Psychiatry2012; 20: 133–141.
58.
QuintoRMRussoFScafutoF, et al.Effects of a body-based mindfulness program on alexithymia, dispositional mindfulness, and distress symptoms: a pilot clinical trial. Behav Sci (Basel)2025; 15: 55.
59.
TsubakiKShimizuE. Psychological treatments for alexithymia: a systematic review. Behav Sci (Basel)2024; 14: 1173.
60.
RaDAgH. Visual dysfunction in dementia with Lewy bodies. Curr Neurol Neurosci Rep2024; 24: 273–284.
61.
KangSYoonSHNaHK, et al.Neuropsychological comparison of patients with Alzheimer’s disease and dementia with Lewy bodies. J Clin Neurol2023; 19: 521–529.
62.
TengELuPHCummingsJL. Deficits in facial emotion processing in mild cognitive impairment. Dement Geriatr Cogn Disord2007; 23: 271–279.
63.
RosenHJWilsonMRSchauerGF, et al.Neuroanatomical correlates of impaired recognition of emotion in dementia. Neuropsychologia2006; 44: 365–373.
64.
RosenHJPace-SavitskyKPerryRJ, et al.Recognition of emotion in the frontal and temporal variants of frontotemporal dementia. Dement Geriatr Cogn Disord2004; 17: 277–281.
65.
BussèCCaffarraPRossiA, et al.Testing hippocampal memory in prodromal dementia with Lewy bodies. J Alzheimers Dis2018; 64: 349–353.
66.
QuerryMBlancFBousigesO, et al.Memory outcome in prodromal and mild dementia with Lewy bodies and Alzheimer’s disease: a longitudinal study. J Alzheimers Dis2023; 94: 147–162.
67.
GilR. 19 - Neuropsychologie de la cognition sociale. In: GilR (ed.) Neuropsychologie (Huitième Édition). Paris: Elsevier Masson, 2024, pp.423–460.
Supplementary Material
Please find the following supplemental material available below.
For Open Access articles published under a Creative Commons License, all supplemental material carries the same license as the article it is associated with.
For non-Open Access articles published, all supplemental material carries a non-exclusive license, and permission requests for re-use of supplemental material or any part of supplemental material shall be sent directly to the copyright owner as specified in the copyright notice associated with the article.
